INTERNATIONAL PATENT: LEADERNA THERAPEUTICS, LTD., 成都先衍生物技术有限公司 FILES APPLICATION FOR "MODIFIED NUCLEOSIDE COMPOUND AND USE THEREOF IN OLIGONUCLEOTIDES"

GENEVA, Dec. 29 -- LEADERNA THERAPEUTICS, LTD. (Building 6, No.8, Huigu 1st East Road Tianfu International Bio-Town Shuangliu DistrictChengdu, Sichuan 610219), 成都先衍生物技术有限公司 (中国四川省成都市双流区（天府国际生物城）慧谷东一路8号6栋) filed a patent application (PCT/CN2025/101633) for "MODIFIED NUCLEOSIDE COMPOUND, AND USE THEREOF IN OLIGONUCLEOTIDES" on Jun 18, 2025. With publication no. WO/2025/261379, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent a...